Hydrogen sulfide attenuates the inflammatory response in a mouse burn injury model

Molecular Medicine Reports

Volumn 8, Issue 4, 2013, Pages 1204-1208

  Zeng, Jianhong ^a   Lin, Xianhe ^b   Fan, Haipeng ^c   Li, Changqing ^d  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Burn injury; Cytokine; Hydrogen sulfide; Inflammation

Indexed keywords

HYDROGEN SULFIDE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; SODIUM CHLORIDE; SODIUM HYDROSULFIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; IL10 PROTEIN, MOUSE; PEROXIDASE; SODIUM BISULFIDE; SULFIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BURN; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; BURNS; C57BL MOUSE; ENZYMOLOGY; IMMUNOLOGY; LIVER; METABOLISM;

MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BURNS; HYDROGEN SULFIDE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LIVER; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; SULFIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883335910     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1610     Document Type: Article

References (35)

1. Shakespeare P: Burn wound healing and skin substitutes. Burns 27: 517-522, 2001.
2. Evers LH, Bhavsar D and Mailänder P: The biology of burn injury. Exp Dermatol 19: 777-783, 2010.
3. Miller CL and Baker CC: Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest 63: 202-210, 1979.
4. Hansbrough JF, Zapata-Sirvent R, Peterson V, et al: Characterization of the immunosuppressive effect of burned tissue in an animal model. J Surg Res 37: 383-393, 1984.
5. Pae HO, Lee YC, Jo EK and Chung HT: Subtle interplay of endogenous bioactive gases (NO, CO and H(2)S) in inflammation. Arch Pharm Res 32: 1155-1162, 2009.
6. Wallace JL: Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid Redox Signal 12: 1125-1133, 2010.
7. Bian JS, Yong QC, Pan TT, et al: Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316: 670-678, 2006.
8. Fiorucci S, Antonelli E, Mencarelli A, et al: The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42: 539-548, 2005.
9. Whiteman M and Winyard PG: Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol 4: 13-32, 2011.
10. Zhang J, Sio SW, Moochhala S and Bhatia M: Role of hydrogen sulfide in severe burn injury-induced inflammation in mice. Mol Med 16: 417-424, 2010
11. Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM and Moore PK: Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J 19: 623-625, 2005.
12. Collin M, Anuar FB, Murch O, Bhatia M, Moore PK and Thiemermann C: Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol 146: 498-505, 2005.
13. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G and Wallace JL: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: 2118-2120, 2006.
14. Elrod JW, Calvert JW, Morrison J, et al: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560-15565, 2007.
15. Sidhapuriwala J, Li L, Sparatore A, Bhatia M and Moore PK: Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat. Eur J Pharmacol 569: 149-154, 2007.
16. Hu LF, Wong PT, Moore PK and Bian JS: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 100: 1121-1128, 2007.
17. Stevenson JM, Gamelli RL and Shankar R: A mouse model of burn wounding and sepsis. Methods Mol Med 78: 95-105, 2003.
18. Geng B, Cui Y, Zhao J, et al: Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol 293: R1608-R1618, 2007.
19. Bhatia M, Saluja AK, Hofbauer B, et al: Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci USA 95: 4760-4765, 1998.
20. Church D, Elsayed S, Reid O, Winston B and Lindsay R: Burn wound infections. Clin Microbiol Rev 19: 403-434, 2006.
21. Endorf FW and Ahrenholz D: Burn management. Curr Opin Crit Care 17: 601-605, 2011.
22. Dahiya P: Burns as a model of SIRS. Front Biosci 14: 4962-4967, 2009.
23. Greenhalgh DG, Saffle JR, Holmes JH IV, et al: American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 28: 776-790, 2007.
24. Oh GS, Pae HO, Lee BS, et al: Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41: 106-119, 2006.
25. Kubo S, Doe I, Kurokawa Y, Nishikawa H and Kawabata A: Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 232: 138-146, 2007.
26. Cone JB, Wallace BH, Lubansky HJ and Caldwell FT: Manipulation of the inflammatory response to burn injury. J Trauma 43: 41-46, 1997.
27. Cohen J: The immunopathogenesis of sepsis. Nature 420: 885-891, 2002.
28. Bhatia M: Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy 1: 343-351, 2002.
29. Nijsten MW, Hack CE, Helle M, ten Duis HJ, Klasen HJ and Aarden LA: Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 109: 761-767, 1991.
30. Hack CE, Hart M, van Schijndel RJ, et al: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60: 2835-2842, 1992.
31. Makhija R and Kingsnorth AN: Levels of the chemokines growth-related oncogene alpha and epithelial neutrophil-activating protein 78 are raised in patients with severe acute pancreatitis. Br J Surg 89: 566-572, 2002.
32. Torre D, Tambini R, Aristodemo S, et al: Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome. Mediators Inflamm 9: 193-195, 2000.
33. Tamayo E, Alvarez FJ, Alonso O, et al: Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. J Cardiovasc Surg (Torino) 50: 687-694, 2009.
34. Volpato GP, Searles R, Yu B, et al: Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 108: 659-668, 2008.
35. Barber RC, Maass DL, White DJ and Horton JW: Increasing percent burn is correlated with increasing inflammation in an adult rodent model. Shock 30: 388-393, 2008.